Kiniksa Pharmaceuticals International, plc
KNSA· Nasdaq
Kiniksa Pharmaceuticals International, plc
- Last sale
- Oct 1, 2026 · +0.91%
- Market cap
- $11.74B
- 156.05M shares
- Filings
- 763
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $677,564,000 | reported | |
| FY 2024 | 2024-12-31 | $423,239,000 | reported | |
| FY 2023 | 2023-12-31 | $270,259,000 | reported | |
| FY 2022 | 2022-12-31 | $220,180,000 | reported | |
| FY 2021 | 2021-12-31 | $38,544,000 | reported |
Kiniksa Pharmaceuticals International, plc · CIK 1730430 · Engraved from SEC EDGAR
